Assessment of the Benefit of Teleconsultations for Children With Autism Spectrum Disorders

Autism Spectrum Disorder Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02996708
• Other study ID #: TLM Prometted
• Status: Recruiting
• Phase: N/A
• First received: December 15, 2016
• Last updated: December 15, 2016
• Start date: January 2014
• Est. completion date: December 2017

Study information

• Verified date: December 2016
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Isabelle Durand-Zaleski, MD, PhD
• Email: isabelle.durand-zaleski[@]aphp.fr
• Is FDA regulated: No
• Health authority: France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine whether Teleconsultation would a)be effective and cost-effective by increasing the proportion of patients with Autism Spectrum Disorders having a correct follow-up, and less transportation, and b) get a high satisfaction from the parents and from the professionals

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 102
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• All residents of medico-social structures accepting children and adolescent with autism disorders

Exclusion Criteria:

• Refusal of parents that their child use telemedicine

• Refusal of parents that their child participate to the research

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Autism Spectrum Disorder
• Autistic Disorder
• Child Autism
• Child Development Disorders, Pervasive

Locations

Country	Name	City	State
France	IME notre Ecole	Carrieres sur Poissy
France	Association Agir et Vivre l'Autisme	Chambourcy
France	IME Eclair	Collegien
France	Association UNI-TEDS	Dammarie les Lys
France	Hôpital Sainte Anne	Paris
France	IME Le Reverdi	Vert saint denis

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Composite score: CARS, VABS evaluated once a year and ADI-R at least once in the lifetime	Score equals 1 if all three evaluations are performed, 0 otherwise	One year after the start of the "before" period and one year after the start of the "after" period	No